Latanoprost and Lamisil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Latanoprost (latanoprost) and Lamisil (terbinafine hydrochloride). Common drug interactions include dyspnoea among females and hepatic enzyme increased among males.

The phase IV clinical study analyzes what interactions people have when they take Latanoprost and Lamisil. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Latanoprost?

Latanoprost has active ingredients of latanoprost. It is often used in glaucoma. eHealthMe is studying from 33,249 Latanoprost users. Check the latest studies of Latanoprost.

What is Lamisil?

Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 14,080 Lamisil users. Check the latest studies of Lamisil.

On Jul, 08, 2026

21 people who take Latanoprost and Lamisil together, and have interactions are studied.

Latanoprost and Lamisil drug interactions.

What are the common drug interactions of Latanoprost and Lamisil, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Memory impairment
Abasia (inability to walk)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Dysgraphia (impaired ability to learn to write)
Dyskinesia (abnormality or impairment of voluntary movement)
Dystonia (abnormal muscle tone)
Fatigue (feeling of tiredness)
Lower respiratory tract infection
Malaise (a feeling of general discomfort or uneasiness)

male:

Hepatic enzyme increased
Amputation
Rash
White blood cell count increased
Anxiety disorder
Back pain
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Depression
Discomfort
Fall

What are the common drug interactions of Latanoprost and Lamisil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Abasia (inability to walk)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Dysgraphia (impaired ability to learn to write)
Dyskinesia (abnormality or impairment of voluntary movement)
Dyspnoea (difficult or laboured respiration)
Dystonia (abnormal muscle tone)
Fatigue (feeling of tiredness)
Lower respiratory tract infection
Malaise (a feeling of general discomfort or uneasiness)
Memory impairment

60+:

Eosinophil count increased
Rash
Hepatic enzyme increased
Hyperlipidaemia (presence of excess lipids in the blood)
Infusion site erythema (reddening of the skin at infusion site)
Infusion site induration
Infusion site pain
Infusion site swelling
Memory impairment
Muscular weakness (muscle weakness)

What are the existing conditions these people have? *

Weight Loss: 3 people, 14.29%
Mycobacterial Infection: 3 people, 14.29%
Multiple Myeloma (cancer of the plasma cells): 3 people, 14.29%
Cellulite (fat deposition under the skin of thigh): 3 people, 14.29%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 9.52%
Constipation: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Latanoprost and Lamisil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously